Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette–Guérin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy-Reference-Cited by-同舟云学术

Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette–Guérin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy

Published:2024-04-29 Issue:18 Volume:18 Page:11910-11920
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Liu Kangkang¹,Peng Jing²³,Guo Yunfei²,Li Yiming²,Qi Xiang²,Duan Dengyi²,Li Taipeng¹,Li Jianmin¹,Niu Yuanjie¹,Han Gang³^ORCID,Zhao Yang²³

Affiliation:

1. Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China

2. Department of Radiology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China

3. Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, 364 Plantation Street, LRB 806, Worcester, Massachusetts 01605, United States

Funder

Tianjin Municipal Health Commission

Natural Science Foundation of Tianjin Municipality

Science Fund for Distinguished Young Scholars of Tianjin Municipality

University of Massachusetts

National Natural Science Foundation of China

Tianjin Municipal Education Commission

Tianjin Key Medical Discipline Construction Project

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c01691

Reference30 articles.

1. Neoantigen vaccine: an emerging tumor immunotherapy

2. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

3. Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis

4. An immunogenic personal neoantigen vaccine for patients with melanoma

5. Tumor neoantigens: from basic research to clinical applications